Hyponatremia in the elderly: challenges and solutions
- PMID: 29180859
- PMCID: PMC5694198
- DOI: 10.2147/CIA.S138535
Hyponatremia in the elderly: challenges and solutions
Abstract
Decreased serum sodium concentration is a rather frequent electrolyte disorder in the elderly population because of the presence of factors contributing to increased antidiuretic hormone, the frequent prescription of drugs associated with hyponatremia and also because of other mechanisms such as the "tea and toast" syndrome. The aim of this review is to present certain challenges in the evaluation and treatment of hyponatremia in the elderly population and provide practical solutions. Hyponatremia in elderly subjects is mainly caused by drugs (more frequently thiazides and antidepressants), the syndrome of inappropriate antidiuretic hormone secretion (SIAD) or endocrinopathies; however, hyponatremia is multifactorial in a significant proportion of patients. Special attention is needed in the elderly population to exclude endocrinopathies as a cause of hyponatremia before establishing the diagnosis of SIAD, which then requires a stepped diagnostic approach to reveal its underlying cause. The treatment of hyponatremia depends on the type of hyponatremia. Special attention is also needed to correct serum sodium levels at the appropriate rate, especially in chronic hyponatremia, in order to avoid the osmotic demyelination syndrome. In conclusion, both the evaluation and the treatment of hyponatremia pose many challenges in the elderly population.
Keywords: elderly; hypopituitarism; pituitary; prognosis; sodium.
Conflict of interest statement
Disclosure This review was conducted independently. Professor Elisaf reports personal fees from Astra-Zeneca, grants and personal fees from MSD, personal fees from Pfizer, Abbott, Sanofi-Aventis, Boehringer Ingelheim, Eli-Lilly and GSK. The authors have given talks and attended conferences sponsored by various pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, Lilly, Abbott, Amgen, AstraZeneca, Novartis, Vianex, Teva and MSD. The authors report no other conflicts of interest in this work.
Similar articles
-
Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study.Maturitas. 2013 Dec;76(4):357-63. doi: 10.1016/j.maturitas.2013.08.010. Epub 2013 Sep 7. Maturitas. 2013. PMID: 24094459
-
[Hyponatremia secondary to inappropriate antidiuretic hormone secretion].G Ital Nefrol. 2008 Sep-Oct;25(5):554-61. G Ital Nefrol. 2008. PMID: 18985840 Italian.
-
Diuretic-associated hyponatremia.Semin Nephrol. 2011 Nov;31(6):553-66. doi: 10.1016/j.semnephrol.2011.09.010. Semin Nephrol. 2011. PMID: 22099512 Review.
-
[Hyponatremia in older persons (part I)-keep diagnosis simple : How to detect tricks and avoid pitfalls].Z Gerontol Geriatr. 2020 Jul;53(4):347-356. doi: 10.1007/s00391-020-01736-z. Epub 2020 Jun 2. Z Gerontol Geriatr. 2020. PMID: 32488305 German.
-
Ten pitfalls in the proper management of patients with hyponatremia.Postgrad Med. 2016 Jun;128(5):516-22. doi: 10.1080/00325481.2016.1186488. Epub 2016 May 24. Postgrad Med. 2016. PMID: 27153450 Review.
Cited by
-
Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up.Clin Diabetes Endocrinol. 2021 Mar 17;7(1):6. doi: 10.1186/s40842-021-00119-6. Clin Diabetes Endocrinol. 2021. PMID: 33731193 Free PMC article.
-
Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia.Korean J Intern Med. 2022 Nov;37(6):1120-1137. doi: 10.3904/kjim.2022.174. Epub 2022 Oct 17. Korean J Intern Med. 2022. PMID: 36245341 Free PMC article. Review.
-
Furosemide and spironolactone doses and hyponatremia in patients with heart failure.BMC Pharmacol Toxicol. 2020 Aug 3;21(1):57. doi: 10.1186/s40360-020-00431-4. BMC Pharmacol Toxicol. 2020. PMID: 32746925 Free PMC article.
-
Factors Associated with Hyponatremia in Patients Newly Prescribed Citalopram: A Retrospective Observational Study.Drugs Real World Outcomes. 2021 Dec;8(4):555-563. doi: 10.1007/s40801-021-00257-4. Epub 2021 May 23. Drugs Real World Outcomes. 2021. PMID: 34024030 Free PMC article.
-
[Consensus recommendations on the diagnosis and treatment of hyponatremia from the Austrian Society for Nephrology 2024].Wien Klin Wochenschr. 2024 Feb;136(Suppl 1):1-33. doi: 10.1007/s00508-024-02325-5. Epub 2024 Feb 29. Wien Klin Wochenschr. 2024. PMID: 38421476 Free PMC article. German.
References
-
- Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med. 2013;126(3):256–263. - PubMed
-
- Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337(1–2):169–172. - PubMed
-
- Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Semin Nephrol. 2009;29(3):227–238. - PubMed
-
- Lindner G, Pfortmuller CA, Leichtle AB, Fiedler GM, Exadaktylos AK. Age-related variety in electrolyte levels and prevalence of dysnatremias and dyskalemias in patients presenting to the emergency department. Gerontology. 2014;60(5):420–423. - PubMed
-
- Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119(1):71.e1–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources